Pharmacology

Action Mechanism of Action Reference
INHIBITOR Programmed cell death protein 1 inhibitor

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Neoplasms 4 D009369 ClinicalTrials
Carcinoma, Squamous Cell 4 D002294 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Melanoma 3 D008545 ClinicalTrials
Uterine Cervical Neoplasms 3 D002583 ClinicalTrials
Carcinoma, Non-Small-Cell Lung 3 D002289 ClinicalTrials
Colorectal Neoplasms 2 D015179 ClinicalTrials
Lymphoma 2 D008223 ClinicalTrials
Hodgkin Disease 2 D006689 ClinicalTrials
Multiple Myeloma 2 D009101 ClinicalTrials
Pancreatic Neoplasms 2 D010190 ClinicalTrials
Hemangiosarcoma 2 D006394 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Prostatic Neoplasms, Castration-Resistant 2 D064129 ClinicalTrials
Oropharyngeal Neoplasms 2 D009959 ClinicalTrials
Carcinoma, Merkel Cell 2 D015266 ClinicalTrials
Skin Neoplasms 2 D012878 ClinicalTrials
Liposarcoma 2 D008080 ClinicalTrials
Breast Neoplasms 2 D001943 ClinicalTrials
Glioblastoma 2 D005909 ClinicalTrials
HIV Infections 1 D015658 ClinicalTrials
Hepatitis B, Chronic 1 D019694 ClinicalTrials
Lymphoma, Follicular 1 D008224 ClinicalTrials
Carcinoma, Renal Cell 1 D002292 ClinicalTrials
Urogenital Neoplasms 1 D014565 ClinicalTrials
Fallopian Tube Neoplasms 1 D005185 ClinicalTrials
Diffuse Intrinsic Pontine Glioma 1 D000080443 ClinicalTrials
Head and Neck Neoplasms 1 D006258 ClinicalTrials
Ovarian Neoplasms 1 D010051 ClinicalTrials
Mycosis Fungoides 1 D009182 ClinicalTrials
Stomach Neoplasms 1 D013274 ClinicalTrials
Neoplasm Metastasis 1 D009362 ClinicalTrials
Urinary Bladder Neoplasms 1 D001749 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL4297723
FDA SRS 6QVL057INT